Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Hong Kong Chinese
100%
Chinese Adults
100%
Metabolic Syndrome
100%
Adipokines
100%
Cardiometabolic Risk
100%
Central Obesity
100%
Metabolic Risk Factors
37%
Obesity
25%
Tumor Necrosis Factor-α
25%
Hypertension
25%
Adiponectin
25%
Leptin
25%
Hypertriglyceridemia
25%
Inflammatory Activity
25%
Insulin Resistance
12%
Asian Population
12%
Asia
12%
Interleukin-6
12%
Hyperglycemia
12%
Interleukin-8
12%
United States
12%
Insulin
12%
High-density Lipoprotein Cholesterol (HDL-C)
12%
Interleukin-10
12%
Blood Samples
12%
Dyslipidemia
12%
Pathophysiological Changes
12%
Pre-diabetes (pre-DM)
12%
Expert Panel
12%
Plasminogen Activator inhibitor-1 (PAI-1)
12%
Patients with Diabetes
12%
Resistin
12%
Complex Disorders
12%
Circulating Levels
12%
Pro-inflammatory Status
12%
Chemokine (C-C motif) Ligand 2 (CCL2)
12%
Visfatin
12%
Patient Identification
12%
Interacting Effects
12%
Associated Morbidity
12%
National Cholesterol Education Program
12%
Adult Treatment Panel III
12%
Chemerin
12%
Medicine and Dentistry
Metabolic Syndrome
100%
Cardiometabolic Risk
100%
Adipocytokine
100%
Adiponectin
18%
Leptin
18%
Hypertriglyceridemia
18%
Tumor Necrosis
18%
Diseases
9%
Biological Marker
9%
Diabetes
9%
Secretion (Process)
9%
Interleukin 6
9%
Interleukin 10
9%
Chemokine
9%
Anti-Inflammatory Drug
9%
Dyslipidemia
9%
High Density Lipoprotein Cholesterol
9%
Hyperglycemia
9%
Impaired Glucose Tolerance
9%
Insulin Resistance
9%
Interleukin 8
9%
Plasminogen Activator Inhibitor-1
9%
Resistin
9%
Chemerin
9%
Nicotinamide Phosphoribosyltransferase
9%
Nursing and Health Professions
Adipocytokine
100%
Central Obesity
100%
Metabolic Syndrome X
100%
Adiponectin
18%
Leptin
18%
Tumor Necrosis
18%
Hypertriglyceridemia
18%
Practice Guideline
9%
Diseases
9%
Biological Marker
9%
Insulin Resistance
9%
Resistin
9%
High Density Lipoprotein Cholesterol
9%
Interleukin 6
9%
Impaired Glucose Tolerance
9%
Plasminogen Activator Inhibitor 1
9%
Hyperglycemia
9%
Nicotinamide Phosphoribosyltransferase
9%
Dyslipidemia
9%
Interleukin 8
9%
Chemerin
9%
Chemokine
9%
Interleukin 10
9%
Pharmacology, Toxicology and Pharmaceutical Science
Metabolic Syndrome X
100%
Adipocytokine
100%
Adiponectin
18%
Leptin
18%
Tumor Necrosis
18%
Hypertriglyceridemia
18%
Insulin Resistance
9%
Diseases
9%
Interleukin 6
9%
Biological Marker
9%
Chemokine
9%
Anti-Inflammatory Drug
9%
High Density Lipoprotein Cholesterol
9%
Hyperglycemia
9%
Interleukin 10
9%
Plasminogen Activator Inhibitor 1
9%
Dyslipidemia
9%
Interleukin 8
9%
Impaired Glucose Tolerance
9%
Resistin
9%
Chemerin
9%
Nicotinamide Phosphoribosyltransferase
9%